Literature DB >> 28315328

TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.

Shin Takeuchi1, Atsushi Kasamatsu2, Masanobu Yamatoji3, Dai Nakashima1, Yosuke Endo-Sakamoto3, Nao Koide1, Toshikazu Takahara1, Toshihiro Shimizu4, Manabu Iyoda5, Katsunori Ogawara6, Masashi Shiiba7, Hideki Tanzawa8, Katsuhiro Uzawa9.   

Abstract

TEA domain transcription factor 4 (TEAD4), which has critical functions in the process of embryonic development, is expressed in various cancers. However, the important role of TEAD4 in human oral squamous cell carcinomas (OSCCs) remain unclear. Here we investigated the TEAD4 expression level and the functional mechanism in OSCC using quantitative reverse transcriptase-polymerase chain reaction, Western blot analysis, and immunohistochemistry. Furthermore, TEAD4 knockdown model was used to evaluate cellular proliferation, cell-cycle analysis, and the interaction between TEAD4 and Yes-associated protein (YAP) which was reported to be a transcription coactivator of cellular proliferation. In the current study, we found that TEAD4 expression increased significantly in vitro and in vivo and correlated with tumoral size in OSCC patients. TEAD4 knockdown OSCC cells showed decreased cellular proliferation resulting from cell-cycle arrest in the G1 phase by down-regulation of cyclins, cyclin-dependent kinases (CDKs), and up-regulation of CDK inhibitors. We also found that the TEAD4-YAP complex in the nuclei may be related closely to transcriptions of G1 arrest-related genes. Taken together, we concluded that TEAD4 might play an important role in tumoral growth and have potential to be a therapeutic target in OSCCs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human oral squamous cell carcinoma; TEA domain transcription factor 4; Yes-associated protein (YAP)

Mesh:

Substances:

Year:  2017        PMID: 28315328     DOI: 10.1016/j.bbrc.2017.03.050

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation.

Authors:  Xiao Li; Yi-Ying Lin; Jia-Yi Tan; Kang-Lun Liu; Xiao-Ling Shen; Ying-Jie Hu; Rui-Yi Yang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

2.  Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP-E2F1-DNA damage response pathway axis.

Authors:  Yusuke Oku; Naoyuki Nishiya; Takaaki Tazawa; Takaya Kobayashi; Nanami Umezawa; Yasuyo Sugawara; Yoshimasa Uehara
Journal:  FEBS Open Bio       Date:  2018-05-22       Impact factor: 2.693

3.  Activated Yes-Associated Protein Accelerates Cell Cycle, Inhibits Apoptosis, and Delays Senescence in Human Periodontal Ligament Stem Cells.

Authors:  Linglu Jia; Weiting Gu; Yunpeng Zhang; Baoqi Jiang; Xu Qiao; Yong Wen
Journal:  Int J Med Sci       Date:  2018-07-30       Impact factor: 3.738

4.  TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression.

Authors:  Qun Zhang; Hang Fan; Qian Zou; Hongda Liu; Bing Wan; Suhua Zhu; Yangbo Hu; Huijuan Li; ChenXi Zhang; Li Zhou; Qingqing Zhu; Kunhong Xiao; Jianya Zhang; Ping Zhan; Tangfeng Lv; Yong Song
Journal:  J Cell Mol Med       Date:  2018-04-18       Impact factor: 5.310

5.  Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.

Authors:  Yanju Wu; Qianqian Zheng; Yan Li; Guang Wang; Shuting Gao; Xiaodong Zhang; Xu Yan; Xinwen Zhang; Jisheng Xie; Yuanyuan Wang; Xun Sun; Xin Meng; Bo Yin; Biao Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-08-27

6.  Peroxiredoxin1 Knockdown Inhibits Oral Carcinogenesis via Inducing Cell Senescence Dependent on Mitophagy.

Authors:  Yunping Lu; Lingyu Li; Hui Chen; Xinying Jing; Min Wang; Lihua Ge; Jing Yang; Min Zhang; Xiaofei Tang
Journal:  Onco Targets Ther       Date:  2021-01-12       Impact factor: 4.147

7.  Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1.

Authors:  Huan-Tian Zhang; Tao Gui; Ri-Xu Liu; Kui-Leung Tong; Chong-Jie Wu; Zhenyan Li; Xun Huang; Qiu-Tong Xu; Jie Yang; Wang Tang; Yuan Sang; Wanting Liu; Ning Liu; Ryan D Ross; Qing-Yu He; Zhen-Gang Zha
Journal:  Cell Death Dis       Date:  2021-01-25       Impact factor: 8.469

8.  TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT.

Authors:  Zhengnan Huang; Yilin Yan; Pengfei Tang; Jinming Cai; Xiangqian Cao; Zeyi Wang; Fang Zhang; Bing Shen
Journal:  Onco Targets Ther       Date:  2021-02-10       Impact factor: 4.147

9.  Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127).

Authors:  Wuli Zhao; Hong Liu; Junxia Wang; Mengyan Wang; Rongguang Shao
Journal:  J Exp Clin Cancer Res       Date:  2018-05-04

10.  TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma.

Authors:  Wei Zhang; Jin Li; Yaping Wu; Han Ge; Yue Song; Dongmiao Wang; Hua Yuan; Hongbing Jiang; Yanling Wang; Jie Cheng
Journal:  Cancer Cell Int       Date:  2018-11-12       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.